Phosphodiesterases Regulate Airway Smooth Muscle Function in Health and Disease

Current Topics in Developmental Biology

Volumn 79, Issue , 2007, Pages 61-74

  Krymskaya, Vera P ^a   Panettieri Jr , Reynold A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYCLIC AMP; CYTOKINE; PHOSPHODIESTERASE;

AIRWAY RESISTANCE; ANIMAL; ENZYMOLOGY; HISTOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; RESPIRATORY SYSTEM; REVIEW; SECRETION; SMOOTH MUSCLE;

AIRWAY RESISTANCE; ANIMALS; CHEMOKINES; CYCLIC AMP; CYTOKINES; HUMANS; MUSCLE, SMOOTH; PHOSPHORIC DIESTER HYDROLASES; RESPIRATORY SYSTEM;

EID: 34248158320     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(06)79003-2     Document Type: Review

References (63)

1. Ahumada A., Slusarski D.C., Liu X., Moon R.T., Malbon C.C., and Wang H.-Y. Signaling of rat frizzled-2 through phosphodiesterase and cyclic GMP. Science 298 (2002) 2006-2010
2. Ammit A.J., and Panettieri Jr. R.A. Signal transduction in smooth muscle: Invited review: The circle of life: Cell cycle regulation in airway smooth muscle. J. Appl. Physiol. 91 (2001) 1431-1437
3. Ammit A.J., Hoffman R.K., Amrani Y., Lazaar A.L., Hay D.W.P., Torphy T.J., Penn R.B., and Panettieri Jr. R.A. Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. modulation by cyclic adenosine monophosphate. Am. J. Respir. Cell Mol. Biol. 23 (2000) 794-802
4. Amrani Y., and Panettieri R. Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 39-45
5. Ariga M., Neitzert B., Nakae S., Mottin G., Bertrand C., Pruniaux M.P., Jin S.-L.C., and Conti M. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation. J. Immunol. 173 (2004) 7531-7538
6. Austin D.R., Chan S.C., Hanifin J.M., Downes H., Parks C., and Hirshman C.A. Cyclic nucleotide function in trachealis muscle of dogs with and without airway hyperresponsiveness. J. Appl. Physiol. 63 (1987) 2309-2314
7. Bai Y., and Sanderson M.J. Modulation of the Ca2+ sensitivity of airway smooth muscle cells in murine lung slices. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L208-L221
8. Bardin P.G., Dorward M.A., Lampe F.C., Franke B., and Holgate S.T. Effect of selective phosphodiesterase 3 inhibition on the early and late asthmatic responses to inhaled allergen. Br. J. Clin. Pharmacol. 45 (1998) 387-391
9. Barnes P. Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 8 (1995) 457-462
10. Beavo J.A., and Brunton L.L. Cyclic nucleotide research-still expanding after half a century. Nat. Rev. Mol. Cell Biol. 3 (2002) 710-718
11. Berkman N., Krishman V.L., Gilbey T., Newton R., O'Connor B., Barnes P.J., and Chung K.F. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am. J. Respir. Cell Mol. Biol. 154 (1996) 1804-1811
12. Billington C.K., Joseph S.K., Swan C., Scott M.G.H., Jobson T.M., and Hall I.P. Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition. Am. J. Physiol. Lung Cell Mol. Physiol. 276 (1999) L412-L419
13. Burnett A.L. Phosphodiesterase 5 mechanisms and therapeutic applications. Am. J. Cardiol. 96 (2005) 29-31
14. Chung K.F. Phosphodiesterase inhibitors in airways disease. Eur. J. Pharmacol. 533 (2006) 110-117
15. Conti M., and Jin S.L. The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 63 (1999) 1-38
16. Conti M., Richter W., Mehats C., Livera G., Park J.-Y., and Jin C. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 278 (2003) 5493-5496
17. Davis R.L., and Dauwalder B. The Drosophila dunce locus: Learning and memory genes in the fly. Trends Genet. 7 (1991) 224-229
18. de Rooij J., Zwartkruis F.J.T., Verheijen M.H.G., Cool R.H., Nijman S.M.B., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
19. Douglas J.S., Lewis A.J., Rodgway P., Brink C., and Bouhuys A. Tachyphylaxis to beta-adrenoreceptor agonists in guinea pig airway smooth muscle in vivo and in vitro. Eur. J. Pharmacol. 42 (1977) 195-205
20. Dudai Y., Jan Y.-N., Byers D., Quinn W.G., and Benzer S. Dunce, a mutant of drosophila deficient in learning. Proc. Natl. Acad. Sci. USA 73 (1976) 1684-1688
21. Essayan D.M. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem. Pharmacol. 57 (1999) 965-973
22. Essayan D.M. Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol. 108 (2001) 671-680
23. Gabella G. Hypertrophic smooth muscle. I. Size and shape of cells, occurence of mitosis. Cell Tissue Res. 201 (1979) 63-78
24. Giembycz M.A. Phosphodiesterase-4: Selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2 (2005) 326-333
25. Gizycki M., Adelroth E., Rogers A., O'Byrne P., and Jeffery P. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell Mol. Biol. 16 (1997) 664-673
26. Goncharova E.A., Billington C.K., Irani C., Vorotnikov A.V., Tkachuk V.A., Penn R.B., Krymskaya V.P., Panettieri J., and Reynold A. Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am. J. Respir. Cell Mol. Biol. 29 (2003) 19-27
27. Hansen G., Jin S.-L.C., Umetsu D.T., and Conti M. Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc. Natl. Acad. Sci. USA 97 (2000) 6751-6756
28. Hedman S.E., and Andersson R.G. The cyclic AMP system in sensitized and desensitized guinea-pig tracheal smooth muscle. Eur. J. Pharmacol. 83 (1982) 107-112
29. Houslay M.D. Adaptation in cyclic AMP signalling processes: A central role for cyclic AMP phosphodiesterases. Semin. Cell Dev. Biol. 9 (1998) 161-167
30. Houslay M.D., and Adams D.R. PDE4 cAMP phosphodiesterases: Modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370 (2003) 1-18
31. Jeffery P.K. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1 (2004) 176-183
32. Jin S.-L.C., and Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc. Natl. Acad. Sci. USA 99 (2002) 7628-7633
33. Jin S.-L.C., Richard F.J., Kuo W.-P., D'Ercole A.J., and Conti M. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc. Natl. Acad. Sci. USA 96 (1999) 11998-12003
34. Jin S.-L.C., Lan L., Zoudilova M., and Conti M. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J. Immunol. 175 (2005) 1523-1531
35. Kume H., Graziano M., and Kotlikoff M. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins. Proc. Natl. Acad. Sci. USA 89 (1992) 11051-11055
36. Kume H., Hall I.P., Washabau R., and Kotlikoff M.I. Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J. Clin. Invest. 93 (1994) 371-379
37. Lazaar A.L., and Panettieri R.A. Airway smooth muscle as an immunomodulatory cell: A new target for pharmacotherapy?. Curr. Opin. Pharmacol. 1 (2001) 259-264
38. Lazaar A.L., Albelda S.M., Pilewski J.M., Brennan B., Pure E., and Panettieri R.A. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 180 (1994) 807-816
39. Lehnart S.E., Wehrens X.H.T., Reiken S., Warrier S., Belevych A.E., Harvey R.D., Ruchter W., Jin C., Conti M., and Marks A.R. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123 (2005) 25-35
40. Madison J.M. Migration of airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 29 (2003) 8-11
41. Malqvist U., and Arner A. Contractile properties during development of hypertrophy of the smooth muscle in the rat portal vein. Acta Physiol. Scand. 133 (1988) 49-61
42. Mehants C., Jin S.-L.C., Wahlstrom J., Law E., Umetsu D.T., and Conti M. PDE4D plays a critical role in the control of airway smooth muscle contraction. FASEB J. 17 (2003) 1831-1841
43. Newman D.J., Colella D.F., Spainhour Jr. C.B., Brann E.G., Zabko-Potapovich B., and Wardell Jr. J.R. cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation. Biochem. Pharmacol. 27 (1978) 729-732
44. Owens G.K., Geisterfer A.A.T., Wei-Hwa Yang Y., and Komoriya A. Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J. Cell Biol. 107 (1988) 771-780
45. Pang L., and Knox A.J. Synergistic inhibition by β2-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am. J. Respir. Cell Mol. Biol. 23 (2000) 79-85
46. Pang L., and Knox A.J. Regulation of TNF-α-induced eotaxin release from cultured human airway smooth muscle cells by β2-agonists and corticosteroids. FASEB J. 15 (2001) 261-269
47. Polson J.B., Kazanowski J.J., Goldman A.L., and Szentivanyi A. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophyline. Clin. Exp. Pharmacol. Physiol. 5 (1978) 535-539
48. Rabe K.F., Tenor H., Dent G., Schudt C., Liebig S., and Magnussen H. Phosphodiesterase isozymes modulating inherent tone in human airways: Identification and characterization. Am. J. Physiol. 264 (1993) L458-L464
49. Reed T.M., Repaske D.R., Snyder G.L., Greengard P., and Vorhees C.V. Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning. J. Neurosci. 22 (2002) 5188-5197
50. Roovers K., and Assoian R.K. Effects of Rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G1 phase cyclin-dependent kinases. Mol. Cell. Biol. 23 (2003) 4283-4294
51. Siuciak J.A., McCarthy S.A., Chapin D.S., Fujiwara R.A., James L.C., Williams R.D., Stock J.L., McNeish J.D., Strick C.A., Menniti F.S., and Schmidt C.J. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function. Neuropharmacology 51 (2006) 374-385
52. Soderling S.H., and Beavo J.A. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions. Curr. Opin. Cell Biol. 12 (2000) 174-179
53. Spina D. The potential of PDE4 inhibitors in respiratory disease. Curr. Drug Targets Inflamm. Allergy 3 (2004) 231-236
54. Stewart A.G., Harris T., Fernandes D.J., Schachte L.C., Koutsoubos V., Guida E., Ravenhall C.E., Vadiveloo P., and Wilson J.W. β2-Adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G1 phase of the cell cycle: Role of proteasome degradation of cyclin D1. Mol. Pharmacol. 56 (1999) 1079-1086
55. Sutherland E.W., and Rall T.W. Fractionation and characterization of cyclic adenine ribonucleotide formed by tissue particles. J. Biol. Chem. 232 (1958) 1077-1092
56. Tomlinson P.R., Wilson J.W., and Stewart A.G. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: Relationship to elevated cAMP levels. Biochem. Pharmacol. 49 (1995) 1809-1819
57. Torphy T., and Cieslinski L. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Mol. Pharmacol. 37 (1990) 206-214
58. Torphy T., Undem B., Cieslinski L., Luttmann M., Reeves M., and Hay D. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J. Pharmacol. Exp. Ther. 265 (1993) 1213-1223
59. Triner L., Vulliemoz Y., and Verosky M. Cyclic 3′,5′-adenosine monophosphate and bronchial tone. Eur. J. Pharmacol. 41 (1977) 37-46
60. Vignola A.M. PDE4 inhibitors in COPD-a more selective approach to treatment. Respir. Med. 98 (2004) 495-503
61. Wang H., Lee Y., and Malbon C.C. PDE6 is an effector for the Wnt/Ca2+/cGMP-signalling pathway in development. Biochem. Soc. Trans. 32 (2004) 792-796
62. Wayman C., Phillips S.E., Lunny C., Webb T., Fawcett L., Baxendale R., and Burgess G. Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Int. J. Impot. Res. 17 (2005) 216-223
63. Yang G., McIntyre K.W., Townsend R.M., Shen H.H., Pitts W.J., Dodd J.H., Nadler S.G., McKinnon M., and Watson A.J. Phosphodiesterase 7A-deficient mice have functional T cells. J. Immunol. 171 (2003) 6414-6420